[PHARMA] QoQ Quarter Result on 30-Jun-2016 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- -18.41%
YoY- -7.54%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 618,294 582,816 515,215 531,796 559,195 680,150 524,413 11.59%
PBT 27,777 4,069 19,923 21,487 26,538 23,717 25,337 6.31%
Tax -8,519 -4,969 -7,275 -5,846 -8,068 -7,676 -5,362 36.11%
NP 19,258 -900 12,648 15,641 18,470 16,041 19,975 -2.40%
-
NP to SH 18,923 -836 13,061 14,995 18,379 16,062 19,971 -3.52%
-
Tax Rate 30.67% 122.12% 36.52% 27.21% 30.40% 32.36% 21.16% -
Total Cost 599,036 583,716 502,567 516,155 540,725 664,109 504,438 12.12%
-
Net Worth 544,360 531,169 531,250 524,177 515,906 529,786 534,373 1.24%
Dividend
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Div 10,368 7,773 10,365 12,949 10,354 18,134 23,312 -41.70%
Div Payout % 54.79% 0.00% 79.37% 86.36% 56.34% 112.90% 116.73% -
Equity
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Net Worth 544,360 531,169 531,250 524,177 515,906 529,786 534,373 1.24%
NOSH 259,219 259,377 259,146 258,981 258,859 259,064 259,027 0.04%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 3.11% -0.15% 2.45% 2.94% 3.30% 2.36% 3.81% -
ROE 3.48% -0.16% 2.46% 2.86% 3.56% 3.03% 3.74% -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 238.52 224.93 198.81 205.34 216.02 262.54 202.45 11.53%
EPS 7.30 -0.32 5.04 5.79 7.10 6.20 7.71 -3.57%
DPS 4.00 3.00 4.00 5.00 4.00 7.00 9.00 -41.73%
NAPS 2.10 2.05 2.05 2.024 1.993 2.045 2.063 1.19%
Adjusted Per Share Value based on latest NOSH - 258,981
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 42.90 40.44 35.75 36.90 38.80 47.19 36.39 11.58%
EPS 1.31 -0.06 0.91 1.04 1.28 1.11 1.39 -3.87%
DPS 0.72 0.54 0.72 0.90 0.72 1.26 1.62 -41.73%
NAPS 0.3777 0.3686 0.3686 0.3637 0.358 0.3676 0.3708 1.23%
Price Multiplier on Financial Quarter End Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 -
Price 4.89 5.30 5.58 5.50 5.76 6.36 6.50 -
P/RPS 2.05 2.36 2.81 2.68 2.67 2.42 3.21 -25.82%
P/EPS 66.99 -1,642.66 110.71 94.99 81.13 102.58 84.31 -14.20%
EY 1.49 -0.06 0.90 1.05 1.23 0.97 1.19 16.15%
DY 0.82 0.57 0.72 0.91 0.69 1.10 1.38 -29.29%
P/NAPS 2.33 2.59 2.72 2.72 2.89 3.11 3.15 -18.19%
Price Multiplier on Announcement Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 26/11/15 -
Price 4.72 5.12 5.70 5.62 5.60 6.19 6.50 -
P/RPS 1.98 2.28 2.87 2.74 2.59 2.36 3.21 -27.51%
P/EPS 64.66 -1,586.88 113.10 97.06 78.87 99.84 84.31 -16.20%
EY 1.55 -0.06 0.88 1.03 1.27 1.00 1.19 19.24%
DY 0.85 0.59 0.70 0.89 0.71 1.13 1.38 -27.58%
P/NAPS 2.25 2.50 2.78 2.78 2.81 3.03 3.15 -20.07%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment